New addition to lab highlights: Frank Gupton VCU

I have recently had the opportunity to meet and work with Dr. Frank Gupton. He has made a career in the chemical development of drug candidates at more than one pharma entity (Hoechst and BI to name a couple)….and has taken his talents back to academia at VCU as the department chair of the Chemical and Life Science Engineering department…..quite a facility. Although industry has made an impression in his career, he is making a tremendous impact in continuous methodologies in manufacturing and drug discovery strategies using flow chemistry — and in several areas: catalyst development, API production, impactful methodology including hydrogenation, C-C coupling catalyst development, C-H activation and general approaches to specific targets. This practical paradigm is leading the way with industrial chemists building back into technology shifts across the pharma industry. One recent endeavor I have had the opportunity to join — Center for Rational Catalyst Design – a consortium with the University of South Carolina (with John Regalbuto) and some of the leading catalyst researchers in the country — all with a focus on development and research directed to new catalysts and basic research designed to impact all chemical industries. Anyone in pharma or metal catalyst design should take the time to contact Frank and the CeRCAS for an opportunity to stay in front of the newest developments in ongoing chemical catalyst design and flow chemical methods.

Screen Shot 2015-05-22 at 3.37.47 PM

Screen Shot 2015-05-22 at 3.37.37 PM

A recent example can be found in a continuous flow application in the synthesis of telmisartan. That said you should stay tuned some some of the newer work in catalyst and method development work……I will keep you posted.

Advertisements

How do we address chemical space with flow chemistry?

Having been in the pharma industry most of my career I am a bit biased and probably to a fault. I do see a number of like-minded people within the industry without an ear to ground on what other industries have offered us over the years in there own bubbles. Let me say that what people do in the petro, catalyst and fine chemical industries will vary vastly to what is important in the pharma community, both on methods and scale. And by and large, never the twain do they cross — almost to an alarming amount.

One area I think the medicinal and process chemists in pharma can take a step back and think about would be in the area of high temperature and pressure flow chemistry — the FDA has open arms out on the manufacturing side, so why not get the stakeholders together in discovery and see where the limitations and opportunities exist. My phone has been ringing on where the possibilities might be — let’s take a step back — the IP space has kept the Pharma and Biotech armed against each other over the last 50 years — and although the dynamics are complex, we have been limited by temp and pressure from traditional roots……think about the advances in our recent past – -catalyst development for C-C and C-N formation, CH activation, microwave and flow and this has had a way of lowering energy barrier to doing new small molecule synthesis. I would contend however that we have been limited in temperature to about 250C and 25-30 bar of pressure even including microwave. Why not expand this capability to 500 or 1000C and extend to pressures of 350 bar — just look at the graph below (to include supercritical fluid possibilities). The reason I frown and hold my head low is that I have seen so many pharma companies crippled by the same compounds — how many times am I going to come across the same chemical core — any new cores out there people?

Screen Shot 2015-05-22 at 1.29.30 PM

 

Now that I have the subject set, I have included some homework for all — there are 50-60 current publications showing that it is possible to utilize higher temps and pressures to generate new chemical matter and new strategies — no more excuses that my compound won’t stand up to 350C — think about the residence time as a driving force in the strategy. Below you will see 3-4 approaches to why drug discovery chemists should take this seriously.

In the following slide, Oliver Kappe shows a baseline approach in moving from microwave to CF technology — in doing so, not only do we see how a process intensification works, it also speaks to the way people are thinking in med chem — “I have a reaction at reflux for >6hr and the microwave at 200C brings it down to 10-20 min, then the residence time in flow should be on that order” — and if the reactor allows for a combination of high temp and pressure with a suitable pump, we can access multiple types of reaction space and more importantly IP space. A comparison on three examples start to flesh out that we should include this thinking in our strategies.

Screen Shot 2015-05-22 at 1.41.58 PM

 

Once you get past the inhibition of working above 250C or higher pressures — or both, a different thinking starts to take over….I can use solvents that I can’t apply in the microwave…..I can use solvents that can’t be used in batch at high temps — keep in mind that flow doesn’t have any headspace so THF at 300C is safe. An example below really scratches the surface of how this thinking can be applied — simplifying an old reaction [Gould-Jacobs quinoline synthesis] provides a process to access the desired heterocycle in fewer steps, eliminates the use of high boiling solvents and opens the door previously undescribed chemical space. The scheme below was described in Lengyel L., Nagy T. Zs., Sipos G., Jones R., Dormán Gy., Ürge L., Darvas F., Tetrahedron Lett., 2012; 53; 738-743. At an empirical stage at this point is fortuitous…..this will get mapped out at some point and predictive, but now is an excellent time to include this in the toolbox along with the photochemical and process that haven’t received their due. Added value to this approach can be found in Synthesis of Condensed Heterocycles by the Gould-Jacobs Reaction (OPRD 2015).

Screen Shot 2015-05-22 at 1.42.51 PM

 

Other examples of opportunity — a number of these unimolecular reactions have application but an unmet need in the lab — just waiting for a young enthusiastic chemist ready to make a name for him/herself.

Screen Shot 2015-05-22 at 2.11.15 PM
Tetrahedron Lett., 2012; 53; 738-743
Screen Shot 2015-05-22 at 2.14.08 PM
Eur. J. Org. Chem., 2009, 9, 1321-1325
Screen Shot 2015-05-22 at 2.17.41 PM
Eur. J. Org. Chem., 2009, 9, 1321-1325

Have fun with the reading — embrace it….it’s why we got into this profession.

Mixing organic and aqueous phases in flow – moving forward fast

Enjoying the efforts of of Christopher Hone and his jflowchemistry blog. His latest article on catalyst, organic and liquid phase models for flow reaction chemistry was intriguing to say the least. There is a lot of interest in the ability to mix organic and aqueous phases – and then add reactive gas into the mix as it were. His description of Yap and co-workers at the National University of Singapore indicates that feasibility studies are ongoing to have a cleaner picture of what is controlling this sort of reaction (mass flow, heat transfer). What I enjoyed most is the subtleties of moving from a fixed bed or homogeneous catalysis into a design with the catalyst immobilized in the aqueous phase and work out the parameters — mixing, organic phase wetting, and finally introduction of gas. With the improvement and advancement of catalyst design — nanocatalyst — we may well see a number of new things being applied to flow design in the near future.

Screen Shot 2015-01-27 at 3.54.38 PM

 

Nice job Chris — keep em coming! Happy reading to the audience!

Labeling under flow conditions: Understanding added applications

Stepping outside traditional synthetic labs into specialty applications is not always something we are looking for in the literature, but it is an excellent way to see different techniques which might be utilized in your own labs. Neil Vasdev’s group at the Harvard Medical School specializes in labeling compounds for more advanced analysis – imaging techniques as tracers for the study of advanced disease states. His group has been using flow chemistry and flow hydrogenation for some time so I thought it be interesting for everyone to see the work.

Screen Shot 2015-01-22 at 5.58.10 AM

Two recent publications illustrate their research. In the first publication Chem Commun 2013, 49, 8755  the group uses three examples where they incorporate a label for study into an advanced intermediate C11 or F18 through a microfluidic reaction, followed by a strategic deprotection of a benzyl  group or CBz under flow hydrogenation. Without going into significant detail, the group absolutely needed an optimized profile for these sorts of reactions due to the nature of the labeling and ran a number of studies with variations of solvent, temperature and pressure. It is worth the read to understand the significance of finding a fast, reliable method for multiple processes for their strategies. Labeling and incorporation of more substituents are being explored using these technologies then the literature provides — and the number of uses for flow hydrogenation can’t be undervalued with all of the transformations within.

Screen Shot 2015-01-22 at 6.09.59 AM

 

The second paper, which I found to be even more interesting because it shows the application of the strategy — the imaging of the compounds made. I would be remiss if I didn’t mention Steven Liang from MGH as a critical part of both papers…..but the paper describes a specific compound made under microfluidic flow conditions for the labeling and subsequent study. Mol Imaging. 2014 Sep 1;13:1-5 is where you can find the citation but if you are exceptional at google (hehe) then you can find a pdf of the article.

Enjoy the articles but keep an eye toward uses of these flow techniques in your own discovery efforts — several new applications show up every week. Happy Reading!

 

New Publications to keep your eye on — flow synthesis and enabling tech

Screen Shot 2015-01-20 at 7.41.12 AM

Organic Synthesis: March of the MachinesAngewandte Chemie Int DOI: 10.1002/anie.201410744 Early Addition on-line prior to print — Review focusing on the implications of workflow in a modern organic chemistry lab.

External Trapping of Halomethyllithium Enabled by Flow  Adv. Synth. Catal. 2015, 357, No. 01, 21-27  Trapping and reactions of thermally reactive and unstable intermediates in flow reactors.

Screen Shot 2015-01-20 at 7.45.14 AM

Expanding the toolbox of asymmetric organocatalysis by continuous-flow process Chem. Commun., 2015, Advance Article DOI: 10.1039/C4CC08748H. Recent advances on the asymmetric side

Screen Shot 2015-01-20 at 7.49.41 AM

 

 

 

 

What do you do when flow requires long residence times?

06LCM_MicroReactor_46_Original_178611

There is a lot of talk about how to traverse moving from batch to flow, and how to make the process of finding a good method quicker under flow conditions. There are some factors keeping us from crossing the goal line: I’ve done it this way for so long and it works – why change (cryogenic or several mainstay transformations)?; the reaction takes too much time in a flow set up; and product survivability. I cringe when I hear these things – largely because the mantra for the last 50 years has been if it is going to 50% at 100C, then just heat it up! — Well you can call me a bit of a dummy and you would be right, but flow chemistry can offer efficiencies that a traditional batch reaction can’t — we know that — mass transfer, time spent at specific temperature can be minimized, and I could go on. Listen this isn’t a blanket that I get to throw over all chemistry, but having come from a microwave background, I think the space available for chemical transformations is untapped — we just haven’t gone there often enough……I just can’t simply buy into chemists simply doing the same reaction over and over for 20 years without finding themselves in a new reaction transformation — there is a lot of it out there and we need to untap this potential.

Let’s just improvise here and generate some discussion — -78C for an anion generation — doesn’t need to be that way for flow: the residence time doesn’t equate with 20-30 mins, then quench with an electrophile. Because the the flow in a microreactor allows kinetic conversion, the reaction can be almost immediate followed by diverting the reactive intermediate in several directions — although I have done this following cooling and anion generation in batch nearly 10000 times — and reverse added this to several other flasks….it just isn’t the best way to do it.

Reactions take longer at lower temperature — I guess you can call that a blanket. There are expanding examples of reactions and transformations that moving from batch to flow that simply do not decrease the time spent — that is without raising the temperature — or even temp/pressure if you have the opportunity. In a sense I am talking about reactions that go from 100C to 150-200C, but also reactions we don’t normally think of at temps of 350C. How many of these can you point to from experience? Well many of the products out there survive at these high temps and survive them for short and long reaction times….pharma, Ag, petro, etc. But the nice thing is that it is generally held that many transformations at these high temps can be done in a short time, and with limited “reaction time” at these high temperatures……get used to it; expansing methods are being developed.

So give you chemistry a bit more thought and challenge some of the traditional techniques used. That text book in the corner is starting to collect some dust: find some examples that would serve as a good model outside a batch process.